Oruka Therapeutics Inc (ORKA)

Finanzdaten der Oruka Therapeutics Inc-Aktie (ORKA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	37.53%50.11	36.43	34.43	34.11	28.43
Research and Development	48.42%43.26	29.15	27.64	28.99	24.09
Operating Income/Loss	37.53%-50.11	-36.43	-34.43	-34.11	-28.43
Nonoperating Income/Loss	92.91%8.90	4.61	4.85	3.83	3.86
	29.50%-41.21	-31.82	-29.58	-30.28	-24.57
Attributable To Parent	29.50%-41.21	-31.82	-29.58	-30.28	-24.57